Dokumente im Korb
Helmholtz Zentrum München
|
Imprint
PuSH - Publication Server of Helmholtz Zentrum München
Navigation
Home
Deutsch
Research
Advanced Search
Browse by ...
... Journal
... Publication Type
... Research Data
... Publication Year
Publication overview
Support & Contact
Contact persons
Help
Data protection
Goormachtigh, G.* ; Ouk, T.S.* ; Mougel, A.* ; Tranchand-Bunel, D.* ; Masy, E.* ; Le, Clorennec, C.* ; Feuillard, J.* ;
Bornkamm, G.W.
; Auriault, C.* ; Manet, E.* ; Fafeur, V.* ; Adriaenssens, E.* ; Coll, J.*
Autoactivation of the Epstein-barr virus oncogenic protein LMP1 during type II latency through opposite roles of the NF-kB and JNK signaling pathways.
J. Virol.
80
, 7382-7393 (2006)
Publ. Version/Full Text Volltext
DOI
PMC
Free by publisher
Open Access Green
as soon as Postprint is submitted to ZB.
Abstract
Metrics
Extra information
Epstein-Barr virus (EBV) is associated with several human malignancies where it expresses limited subsets of latent proteins. Of the latent proteins, latent membrane protein 1 (LMP1) is a potent transforming protein that constitutively induces multiple cell signaling pathways and contributes to EBV-associated oncogenesis. Regulation of LMP1 expression has been extensively described during the type III latency of EBV. Nevertheless, in the majority of EBV-associated tumors, the virus is commonly found to display a type II latency program in which it is still unknown which viral or cellular protein is really involved in maintaining LMP1 expression. Here, we demonstrate that LMP1 activates its own promoter pLMP1 through the JNK signaling pathway emerging from the TES2 domain. Our results also reveal that this activation is tightly controlled by LMP1, since pLMP1 is inhibited by LMP1-activated NF-κB signaling pathway. By using our physiological models of EBV-infected cells displaying type II latency as well as lymphoblastoid cell lines expressing a type III latency, we also demonstrate that this balanced autoregulation of LMP1 is shared by both latency programs. Finally, we show that this autoactivation is the most important mechanism to maintain LMP1 expression during the type II latency program of EBV. Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Altmetric
Additional Metrics?
[➜Log in]
Tags
Annotations
Special Publikation
Edit extra informations
Login
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Corresponding Author
Keywords
Keywords plus
ISSN (print) / ISBN
0022-538X
e-ISSN
1098-5514
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Journal
Journal of Virology
Quellenangaben
Volume: 80,
Issue: 15,
Pages: 7382-7393
Article Number: ,
Supplement: ,
Series
Publisher
American Society for Microbiology (ASM)
Publishing Place
University
University place
Faculty
Publication date
0000-00-00
Application number
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Non-patent literature
Publications
Reviewing status
Peer reviewed
Institute(s)
Institute of Clinical Molecular Biology and Tumor Genetics (K.MOLBI)
Grants
Copyright